IWP
REGN icon

IAG Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

IAG Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6K Hold
33
– – ﹤0.01% 308
2026
Q1 		$25.5K Hold
33
– – ﹤0.01% 275
2025
Q4 		$25.5K Hold
33
– – ﹤0.01% 270
2025
Q3 		$18.6K Buy
+33
New +$18.7K ﹤0.01% 310

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

IAG Wealth Partners's REGN Position: Q2 2026 in Review

IAG Wealth Partners held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 33 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #308.

IAG Wealth Partners first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $25.5K in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • IAG Wealth Partners held 33 shares of Regeneron Pharmaceuticals worth $20.6K as of Q2 2026.
  • IAG Wealth Partners left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of IAG Wealth Partners's portfolio in Q2 2026, its #308 holding.
  • IAG Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • IAG Wealth Partners's Regeneron Pharmaceuticals position peaked at $25.5K in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on IAG Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.